
Hearts and Minds combine to continue sustainable funding for medical research
MS Research Australia has been a recipient of funding raised through the Sohn Hearts & Minds Investment Leaders Conference for the past four years.

MS Research Australia has been a recipient of funding raised through the Sohn Hearts & Minds Investment Leaders Conference for the past four years.

Deeper insights into the spine’s electrical connections uncover changes in the nervous system in progressive MS and highlight the power of tissue banks.

Introduction If we thought last year’s Federal Budget was unusual, coming as it did a month early at

Major study into MS and pregnancy reveals it delays onset of MS symptoms by more than 3 years.

The Australian MS Longitudinal Study (AMSLS) run by the Menzies Institute for Medical Research and MS Research Australia is looking for new participants.

Meet Monique Bolland – brand manager at Nuzest, designer, mother, entrepreneur and our newest Kiss Goodbye to MS ambassador.

The Australian Therapeutic Goods Administration (TGA) has approved the first ever treatment for Neuromyelitis Optica Spectrum Disorders (NMOSD).

A panel of international experts have convened to develop new ways to measure disease progression in progressive MS, a major hurdle for clinical trials.

During Include a Charity week, we celebrated the wonderful supporters who generously chose to leave gifts in their wills for MS Research Australia.